Percutaneous treatment of mitral valve disease: repair vs. replacement

Abstract

Severe mitral regurgitation is the second leading cause of cardiac valve intervention in Europe, reaching up to 10% of people older than 75 years. The mitral valve is an anatomically complex structure in which several underlying mechanisms for its malfunction could coexist. Nonetheless, over the last years, development of new techniques and devices, improved patient selection, and dedicated imaging assessment and guidance tools seem to offer novel alternatives for percutaneous mitral valve treatment. The present review aims to provide an update of the available percutaneous techniques for patients with severe mitral regurgitation.

Keywords

Mitral regurgitation / percutaneous techniques

References

[1] Nkomo VT,Skelton TN,Scott CG.Burden of valvular heart diseases: a population-based study.Lancet2006;368:1005-11

[2] Baumgartner H,Bax JJ.2017 ESC/EACTS Guidelines for the management of valvular heart disease.Eur Heart J2017;38:2739-91

[3] Prendergast BD,Delgado V.Transcatheter heart valve interventions: Where are we?.Eur Heart J2019;40:422-440

[4] Del Forno B,Agricola E.Mitral valve regurgitation: a disease with a wide spectrum of therapeutic options.Nat Rev Cardiol2020;17:807-27

[5] Dal-Bianco JP.Anatomy of the mitral valve apparatus: role of 2D and 3D echocardiography.Cardiol Clin2013;31:151-64 PMCID:PMC3856635

[6] Zamorano JL,Lancellotti P.Mitral valve anatomy: Implications for transcatheter mitral valve interventions.EuroIntervention2014;10 Suppl U:U106-11

[7] Pozzoli A,Reisman M,Taramasso M.Comparative anatomy of mitral and tricuspid valve: what can the interventionlist learn from the surgeon.Front Cardiovasc Med2018;5:80 PMCID:PMC6033960

[8] Timek TA,Tibayan FA.Aorto-mitral annular dynamics.Ann Thorac Surg2003;76:1944-50

[9] McCarthy KP,Rana BS.Anatomy of the mitral valve: Understanding the mitral valve complex in mitral regurgitation.Eur J Echocardiogr2010;11:i3-9

[10] Ritchie J,Yoganathan AP.Structural characterization of the chordae tendineae in native porcine mitral valves.Ann Thorac Surg2005;80:189-97

[11] Otto CM.Clinical practice. Evaluation and management of chronic mitral regurgitation.N Engl J Med200;345:740-6

[12] O’Gara PT.Secondary mitral regurgitation.N Engl J Med2020;383:1458-67

[13] Estévez-Loureiro R,Garrote-Coloma C.Percutaneous mitral repair: current and future devices.Ann Transl Med2020;8:963 PMCID:PMC7475444

[14] Otto CM,Bonow RO.2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines.Circulation2021;143:e35-e71

[15] Halim J,Coussement P,Van der Heyden J.Percutaneous mitral valve repair: the necessity to redefine secondary mitral regurgitation.Neth Heart J2020;28:272-9 PMCID:PMC7190777

[16] Acker MA,Perrault LP.Mitral-valve repair versus replacement for severe ischemic mitral regurgitation.N Engl J Med2014;370:23-32 PMCID:PMC4128011

[17] Kumar A,Shariff M,Adalja D.Percutaneous mitral valve repair for secondary mitral valve regurgitation: a systematic review and meta-analysis.Eur J Intern Med2020;78:107-12

[18] Arnold S V.Frail elderly, the ideal patients for mitraclip.JACC Cardiovasc Interv2017;10:1930-1 PMCID:PMC5812355

[19] Metze C,Scherner M.Impact of frailty on outcomes in patients undergoing percutaneous mitral valve repair.JACC Cardiovasc Interv2017;10:1920-9

[20] Chakravarty T,Patel D.Transcatheter edge-to-edge mitral valve repair with the mitraclip G4 system.JACC Cardiovasc Interv2020;13:2402-14

[21] Khan F,Ong G.Percutaneous mitral edge-to-edge repair: state of the art and a glimpse to the future.Front Cardiovasc Med2019;6:122 PMCID:PMC6759865

[22] Huded C.Treatment of functional mitral regurgitation with transcatheter edge-to-edge repair.Interv Cardiol Clin2019;8:235-43

[23] Feldman T,Elmariah S.Randomized comparison of percutaneous repair and surgery for mitral regurgitation 5-year results of EVEREST II.J Am Coll Cardiol2015;66:2844-54

[24] Boekstegers P,Baldus .Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system.Clin Res Cardiol2014;103:85-96

[25] Stone GW,Abraham WT.Transcatheter mitral-valve repair in patients with heart failure.N Engl J Med2018;379:2307-18

[26] Obadia J-F,Leurent G.Percutaneous repair or medical treatment for secondary mitral regurgitation.N Engl J Med2018;379:2297-306

[27] Sherif MA,Yuecel S.Mitraclip step by step; how to simplify the procedure.Neth Heart J2017;25:125-30 PMCID:PMC5260622

[28] Stone GW,Abraham WT.Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions a consensus document from the mitral valve academic research consortium.J Am Coll Cardiol2015;66:308-21

[29] Benito-González T,Villablanca PA.Percutaneous mitral valve repair vs. stand-alone medical therapy in patients with functional mitral regurgitation and heart failure.Cardiovasc Revasc Med2020;21:52-60

[30] Lim DS,Spargias K.Transcatheter valve repair for patients with mitral regurgitation: 30-day results of the CLASP study.JACC Cardiovasc Interv2019;12:1369-78

[31] Miller M,Whisenant B.The Cardioband transcatheter annular reduction system.Ann Cardiothorac Surg2018;7:741-7 PMCID:PMC6288207

[32] Feldman T.Percutaneous approaches to valve repair for mitral regurgitation.J Am Coll Cardiol2014;63:2057-68

[33] Goode D,Mohammadi H.Transcatheter mitral valve replacement: state of the art.Cardiovasc Eng Technol2020;11:229-53

[34] Witte KK,Siminiak T.The REDUCE FMR trial: a randomized sham-controlled study of percutaneous mitral annuloplasty in functional mitral regurgitation.JACC Hear Fail2019;7:945-55

[35] Di Micco L,Colli A.The neochord mitral valve repair procedure: Numerical simulation of different neochords tensioning protocols.Med Eng Phys2019;74:121-8

[36] Randomized Trial of the Neochord^TM DS1000^TM System Versus Open Surgical Repair - Full Text View - ClinicalTrials.gov [Internet]. Available from: https://clinicaltrials.gov/ct2/show/NCT02803957. [Last accessed on 25 Nov 2020]

[37] Regueiro A,Dagenais F.Transcatheter mitral valve replacement: insights from early clinical experience and future challenges.J Am Coll Cardiol2017;69:2175-92

[38] Sondergaard L,Franzen OW.First-in-human case of transfemoral cardiAQ mitral valve implantation.Circ Cardiovasc Interv2015;8:e002135

[39] Bapat V,Meduri C.Early experience with new transcatheter mitral valve replacement.J Am Coll Cardiol2018;71:12-21

[40] Yoon SH,Bleiziffer S.Transcatheter mitral valve replacement for degenerated bioprosthetic valves and failed annuloplasty rings.J Am Coll Cardiol2017;70:1121-31

[41] NAVIGATE Transcatheter Tricuspid Valve Replacement…Early Findings-Technology and Clinical Updates. Available from: https://www.tctmd.com/slide/navigate-transcatheter-tricuspid-valve-replacement-early-findings-technology-and-clinical-0. [Last accessed on 13 Nov 2020]

[42] Cheung A,Verheye S.Short-term results of transapical transcatheter mitral valve implantation for mitral regurgitation.J Am Coll Cardiol2014;64:1814-9

[43] CardioValve: Device Attributes, Implant Procedure, and Early Results. Available from: https://www.tctmd.com/slide/cardiovalve-device-attributes-implant-procedure-and-early-results. [Last accessed on 13 Nov 2020]

[44] New Technology Update: Cephea. Available from: https://www.tctmd.com/slide/new-technology-update-cephea. [Last accessed on 13 Nov 2020]

[45] 4C Medical’s AltaValve: The First Human Experience. Available from: https://www.tctmd.com/slide/4c-medicals-altavalve-first-human-experience. [Last accessed on 13 Nov 2020]

[46] Preston-Maher GL,Burriesci G.A technical review of minimally invasive mitral valve replacements.Cardiovasc Eng Technol2015;6:174-84 PMCID:PMC4427651

[47] Testa L,Casenghi M,Latib A.Transcatheter mitral valve replacement in the transcatheter aortic valve replacement era.J Am Heart Assoc2019;8:e013352 PMCID:PMC6915270

[48] Overtchouk P,Granada J,Prendergast B.Advances in transcatheter mitral and tricuspid therapies.BMC Cardiovasc Disord2020;20:1 PMCID:PMC6945613

[49] Yoon SH,Latib A.Predictors of left ventricular outflow tract obstruction after transcatheter mitral valve replacement.JACC Cardiovasc Interv2019;12:182-93

[50] Coisne A,Tchétché D.Transcatheter mitral valve replacement: Factors associated with screening success and failure.EuroIntervention2019;15:E983-9

[51] Vaquerizo B,Piazza N.Percutaneous transcatheter mitral valve replacement: patient-specific three-dimensional computer-based heart model and prototyping.Rev Española Cardiol2015;68:1165-73

[52] Niikura H,Kshettry V.Causes and clinical outcomes of patients who are ineligible for transcatheter mitral valve replacement.JACC Cardiovasc Interv2019;12:196-204